GW Pharmaceuticals may soon see its epilepsy drug, Epidiolex, approved by the Food & Drug Administration to be a prescription drug.
The drug is made from a component of cannabis that doesn’t give the user the “high,” and is intended for children with severe epilepsy.
Many wonder if the FDA backs the drug, what would it mean for marijuana products that do not have FDA approval.
An attorney in Colorado, who also worked on the pharmaceutical legislation for the drug, told the Associated Press, “The future of the industry is showing itself here.
There’s going to be the pharmaceutical lane, the nutraceutical lane [food as medicine], the adult-use lane. This shows how that’s all coming together.”
FDA advisers unanimously recommended the agency approve the drug back in April and will make a decision by the end of the month.
